Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ceramides improve atherosclerotic cardiovascular disease risk assessment beyond standard risk factors
Jeffrey W. Meeusen, Leslie J. Donato, Stephen L. Kopecky, et al.
Clinica Chimica Acta (2020) Vol. 511, pp. 138-142
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Obesity and dyslipidemia in early life: Impact on cardiometabolic risk
Aleksandra Zeljković, Jelena Vekić, Aleksandra Stefanovic
Metabolism (2024) Vol. 156, pp. 155919-155919
Closed Access | Times Cited: 19
Emerging Roles of Ceramide in Cardiovascular Diseases
Hongyang Shu, Yizhong Peng, Weijian Hang, et al.
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 232-232
Open Access | Times Cited: 41
Four-dimensional trapped ion mobility spectrometry lipidomics for high throughput clinical profiling of human blood samples
Raissa Lerner, Dhanwin Baker, Claudia Schwitter, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 38
Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk
Carmen Annevelink, Philip A. Sapp, Kristina Petersen, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 5, pp. 577-586
Open Access | Times Cited: 30
Research Progress in Pharmacological Effects and Mechanisms of Angelica sinensis against Cardiovascular and Cerebrovascular Diseases
Lin-Lin Chen, Bei Fan, Fengzhong Wang, et al.
Molecules (2024) Vol. 29, Iss. 9, pp. 2100-2100
Open Access | Times Cited: 11
Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis
Onorina L. Manzo, Jasmine Nour, Linda Sasset, et al.
Circulation Research (2024) Vol. 134, Iss. 8, pp. 990-1005
Closed Access | Times Cited: 10
Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout
Aleš Kvasnička, David Friedecký, Barbora Piskláková, et al.
Vascular Pharmacology (2025) Vol. 159, pp. 107495-107495
Closed Access | Times Cited: 1
Ceramide Scores Predict Cardiovascular Risk in the Community
Vlad C. Vasile, Jeffrey W. Meeusen, José R. Medina‐Inojosa, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 4, pp. 1558-1569
Open Access | Times Cited: 55
Ceramide Acyl Chain Length and Its Relevance to Intracellular Lipid Regulation
Qing Wei Calvin Ho, Xiaofeng Zheng, Yusuf Ali
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9697-9697
Open Access | Times Cited: 36
Plasma Ceramide Levels Are Elevated in Patients With Early Coronary Atherosclerosis and Endothelial Dysfunction
Nadia Akhiyat, Vlad C. Vasile, Ali Ahmad, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 7
Open Access | Times Cited: 29
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Alexandra C Finney, Sandeep R. Das, Dhananjay Kumar, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Clinical lipidomics in the era of the big data
Aleš Kvasnička, Lukáš Najdekr, Dana Dobešová, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2023) Vol. 61, Iss. 4, pp. 587-598
Open Access | Times Cited: 19
Replacement of dietary saturated with unsaturated fatty acids is associated with beneficial effects on lipidome metabolites: a secondary analysis of a randomized trial
Laury Sellem, Fabian Eichelmann, Kim G. Jackson, et al.
American Journal of Clinical Nutrition (2023) Vol. 117, Iss. 6, pp. 1248-1261
Open Access | Times Cited: 17
(−)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress in vivo and in vitro
Jinjin Yu, Weifeng Li, Xin Xiao, et al.
Food & Function (2021) Vol. 12, Iss. 18, pp. 8715-8727
Closed Access | Times Cited: 28
Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly
Taina Katajamäki, Marja-Kaisa Koivula, Mika Hilvo, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 12, pp. 1502-1508
Open Access | Times Cited: 21
Marked elevations in lung and plasma ceramide in COVID-19 linked to microvascular injury
Irina Petrache, Elisabet Pujadas, Aditya Ganju, et al.
JCI Insight (2023) Vol. 8, Iss. 10
Open Access | Times Cited: 12
Ceramide in Coronary Artery Disease: Troublesome or Helpful Future Tools in the Assessment of Risk Prediction and Therapy Effectiveness?
Melania Gaggini, Adrian Florentin Suman, Cristina Vassalle
Metabolites (2025) Vol. 15, Iss. 3, pp. 168-168
Open Access
Cer(d18:1/16:0) as a biomarkers for acute coronary syndrome in Chinese populations
Liang Zhang, Yang Zhang, Yaodong Ding, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Plasma lipidomic alterations during pathogenic SIV infection with and without antiretroviral therapy
Sindhuja Sivanandham, Ranjit Sivanandham, Cuiling Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes
Baowen Yu, Moran Hu, Wanzi Jiang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study
Lee Bockus, Paul N. Jensen, Amanda M. Fretts, et al.
JAMA Network Open (2023) Vol. 6, Iss. 11, pp. e2343854-e2343854
Open Access | Times Cited: 7
Serum Ceramides as Prognostic Biomarkers of Large Thrombus Burden in Patients with STEMI: A Micro-Computed Tomography Study
Efstratios Karagiannidis, Αndreas S. Papazoglou, Nikolaos Stalikas, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 89-89
Open Access | Times Cited: 13
Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)
Cara East, Kyle Bass, Ankit Mehta, et al.
Kidney Medicine (2022) Vol. 4, Iss. 7, pp. 100483-100483
Open Access | Times Cited: 9
Longitudinal lipidomic signature of carotid atherosclerosis in American Indians: Findings from the Strong Heart Family Study
Guanhong Miao, Oliver Fiehn, Mingjing Chen, et al.
Atherosclerosis (2023) Vol. 382, pp. 117265-117265
Open Access | Times Cited: 5
The therapeutic potential of sphingolipids for cardiovascular diseases
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top